Dr. Hofmeister's research focus is on early drug development and investigator-initiated clinical trials exploring novel diagnostics and treatments. As a translational researcher, he has been funded continuously from the National Cancer Institute (NCI) since 2016.
Get the latest thought leadership on Myeloma delivered straight to your inbox.
Subscribe to the weekly "HealthTree Community for Myeloma Newsletter" for Myeloma news, life with Myeloma stories, Myeloma clinical trials, Myeloma 101 articles and events with Myeloma experts.
Thanks to our HealthTree Community for Myeloma Sponsors:
Follow Us
Copyright © 2022 HealthTree Foundation. All Rights Reserved.
The HealthTree Foundation / Myeloma Crowd is a qualified 501(c)(3) tax-exempt organization. Tax ID 45-5354811
